ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,015,465 | -9.9% | 144,696 | +3.6% | 0.00% | 0.0% |
| Q2 2023 | $3,345,838 | +16.1% | 139,701 | -8.8% | 0.00% | 0.0% |
| Q1 2023 | $2,883,055 | -50.7% | 153,191 | -58.3% | 0.00% | -50.0% |
| Q4 2022 | $5,847,719 | +600.3% | 367,319 | +619.2% | 0.00% | – |
| Q3 2022 | $835,000 | +75.1% | 51,073 | +51.1% | 0.00% | – |
| Q2 2022 | $477,000 | -69.0% | 33,802 | -46.7% | 0.00% | -100.0% |
| Q1 2022 | $1,537,000 | -71.1% | 63,433 | -72.2% | 0.00% | 0.0% |
| Q4 2021 | $5,319,000 | +41.4% | 227,908 | +0.6% | 0.00% | 0.0% |
| Q3 2021 | $3,761,000 | +638.9% | 226,503 | +986.1% | 0.00% | – |
| Q2 2021 | $509,000 | -45.1% | 20,855 | -42.0% | 0.00% | – |
| Q1 2021 | $927,000 | -55.2% | 35,935 | -7.1% | 0.00% | -100.0% |
| Q4 2020 | $2,067,000 | +65.0% | 38,661 | +27.3% | 0.00% | – |
| Q3 2020 | $1,253,000 | -51.8% | 30,378 | -43.4% | 0.00% | -100.0% |
| Q2 2020 | $2,599,000 | +156.3% | 53,627 | +123.4% | 0.00% | – |
| Q1 2020 | $1,014,000 | -87.3% | 24,005 | -87.1% | 0.00% | -100.0% |
| Q4 2019 | $7,986,000 | +85.8% | 186,672 | +56.3% | 0.00% | +50.0% |
| Q3 2019 | $4,298,000 | +173.2% | 119,422 | +102.9% | 0.00% | +100.0% |
| Q2 2019 | $1,573,000 | -25.9% | 58,857 | -25.5% | 0.00% | 0.0% |
| Q1 2019 | $2,122,000 | -57.1% | 79,007 | -74.2% | 0.00% | -50.0% |
| Q4 2018 | $4,945,000 | -23.1% | 305,814 | -1.2% | 0.00% | -33.3% |
| Q3 2018 | $6,429,000 | +136.9% | 309,674 | +74.2% | 0.00% | +200.0% |
| Q2 2018 | $2,714,000 | -72.5% | 177,743 | -59.5% | 0.00% | -75.0% |
| Q1 2018 | $9,866,000 | +49.5% | 439,087 | +100.3% | 0.00% | +33.3% |
| Q4 2017 | $6,601,000 | -30.7% | 219,222 | -13.3% | 0.00% | -25.0% |
| Q3 2017 | $9,524,000 | +39.4% | 252,835 | +3.2% | 0.00% | 0.0% |
| Q2 2017 | $6,830,000 | +150.3% | 244,880 | +208.5% | 0.00% | +300.0% |
| Q1 2017 | $2,729,000 | -48.4% | 79,377 | -56.7% | 0.00% | -66.7% |
| Q4 2016 | $5,291,000 | +5.3% | 183,482 | +16.1% | 0.00% | 0.0% |
| Q3 2016 | $5,026,000 | -17.5% | 158,010 | -15.8% | 0.00% | -25.0% |
| Q2 2016 | $6,089,000 | +1171.2% | 187,587 | +996.9% | 0.00% | – |
| Q1 2016 | $479,000 | -15.1% | 17,102 | +7.9% | 0.00% | – |
| Q4 2015 | $564,000 | -69.5% | 15,844 | -71.7% | 0.00% | -100.0% |
| Q3 2015 | $1,850,000 | +111.2% | 55,928 | +167.4% | 0.00% | – |
| Q2 2015 | $876,000 | -44.8% | 20,915 | -57.1% | 0.00% | -100.0% |
| Q1 2015 | $1,587,000 | -56.0% | 48,704 | -57.1% | 0.00% | -66.7% |
| Q4 2014 | $3,607,000 | – | 113,621 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |